Retinal neurons derived from human stem cells are a promising supply of alternative cells for regenerating broken or diseased retinas. As scientists progress towards translation of cell therapies for restoring imaginative and prescient, they encounter challenges, together with find out how to ship the cells, be certain that they combine appropriately with host tissue, and allow correct perform after transplantation.
On this episode, Iris Kulbatski from The Scientist spoke with Deepak Lamba, a distinguished scientist within the division of immunology and regenerative medication at Genentech and an affiliate adjunct professor on the College of California, San Francisco, to be taught extra about how advances in cell tradition fashions and related applied sciences assist researchers progress in direction of retinal cell remedy.
Extra on this subject
On-Once more, Off-Once more Connections Advance Eye Regeneration
Donor-Derived iPS Cells Present Promise for Treating Eye Illness
The Scientist Speaks is a podcast produced by The Scientist’s Inventive Providers Group. Our podcast is by scientists and for scientists. As soon as a month, we deliver you the tales behind news-worthy molecular biology analysis. This month’s episode is sponsored by Bio-Rad.
Speaker:
Deepak A. Lamba, MBBS, PhD
Distinguished Scientist
Division of Immunology and Regenerative Drugs
Genentech
Affiliate Adjunct Professor
College of California, San Francisco
Bio-Rad is a worldwide chief in creating, manufacturing, and advertising a broad vary of progressive merchandise for the life science analysis and scientific diagnostics markets. With a concentrate on high quality and customer support for 70 years, our merchandise advance the invention course of and enhance well being care.
